Price
$1.25
Increased by +1.63%
Dollar volume (20D)
260.94 K
ADR%
6.45
Earnings report date
Nov 17, 2025
Shares float
32.93 M
Shares short
1.41 M [4.27%]
Shares outstanding
60.57 M
Market cap
74.51 M
Beta
0.14
Price/earnings
N/A
20D range
1.21 1.60
50D range
1.19 1.78
200D range
0.85 2.41

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.

The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers.

It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug.

Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Reported date EPSChange YoY EstimateSurprise
Aug 12, 25 -0.68
Decreased by -100.00%
-0.51
Decreased by -33.33%
May 12, 25 -0.48
Decreased by -92.00%
-0.55
Increased by +12.09%
Mar 24, 25 -0.62
Decreased by -121.43%
-0.37
Decreased by -69.49%
Nov 13, 24 -0.50
Decreased by -106.42%
-0.36
Decreased by -37.61%
Aug 13, 24 -0.34
Decreased by -21.43%
-0.28
Decreased by -21.43%
May 14, 24 -0.25
Increased by +10.71%
-0.26
Increased by +3.85%
Mar 26, 24 -0.28
Increased by +12.50%
-0.26
Decreased by -7.69%
Nov 13, 23 -0.24
Increased by +7.69%
-0.27
Increased by +11.11%
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 25 0.00
Decreased by N/A%
-40.95 M
Decreased by -99.40%
Decreased by N/A%
Decreased by N/A%
Mar 31, 25 0.00
Decreased by N/A%
-28.80 M
Decreased by -93.61%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 178.00 K
Decreased by -38.62%
-37.15 M
Decreased by -125.22%
Decreased by -20.87 K%
Decreased by -266.93%
Sep 30, 24 0.00
Decreased by N/A%
-29.77 M
Decreased by -129.72%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-20.54 M
Decreased by -76.89%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-14.87 M
Decreased by -56.90%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 290.00 K
Increased by +N/A%
-16.50 M
Decreased by -18.99%
Decreased by -5.69 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-12.96 M
Decreased by -28.94%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY